19 Jun 2019 --- Set to be launched in September, the International Cannabinoid Analysis Program (ICAP) is a new third-party certification program for manufacturers and brands in the hemp and cannabidiol (CBD) products market. ICAP tests cannabis, hemp and their extracts or derivative products with appropriate methods to ensure they contain less than 0.20 percent delta-9-tetrahydrocannabinol (THC) – the legal US limit laid out in the December 2018 Farm Bill. The limit is also in alignment with the European regulations. NutritionInsight speaks to the companies behind the program and the blooming CBD and hemp market.
